ArticleAnnals of thoracic surgery short reports2026
Lung Cancer Screening in Head and Neck Cancer: An Opportunity to Increase Screening in Eligible Candidatess.
Article in Annals of thoracic surgery short reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer screening is as an effective strategy for early diagnosis in high-risk patients, with proven impact on decreasing mortality. Individuals with malignancies of the head and neck have risk factors similar to those with lung cancer, with the most notable being a shared association with current or previous smoking. We evaluated the prevalence of lung cancer screening candidacy and implementation among head and neck cancer clinic patients. Methods: Anonymous surveys were collected from patients who presented to the head and neck cancer clinic at a single, tertiary-care center from May 2024 to August 2024. Individuals were queried regarding their candidacy for and experiences with lung cancer screening. Descriptive analyses were performed. Results: A total of 202 patients were surveyed, with median age of 66 (interquartile range, 15) years. Within this cohort, 77 (38.0%) previously smoked and 15 (7.4%) currently smoked. Among all respondents, 23 (11.4%) met 2021 United States Preventative Service Taskforce criteria for lung cancer screening. Most of the patients (16 [69.6%]) who met criteria had never been offered screening. Seven patients (30.4%) who were eligible for lung cancer screening were previously offered screening and completed it. Of the 25 patients who were screened in the entire cohort, 5 (20%) were diagnosed with lung cancer. Conclusions: A substantial proportion of head and neck cancer patients are eligible for lung cancer screening. The low levels of screening highlighted in this shared patient population serve as an opportunity for quality improvement, especially given the high frequency of cancer diagnoses among those who received screening.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.